Acute renal failure associated with Plasmodium falciparum infection is already well recognized. Nevertheless, end-stage chronic renal failure and falciparum malaria comorbidity is a rare condition. We report a case of Plasmodium falciparum infection in a young male Javanese patient with end-stage chronic renal failure who underwent regular hemodialysis. This rare comorbidity led to rapid deterioration of consciousness and metabolic disturbances which had already existed in end-stage renal failure. Because of the immunosuppressive condition due to organ failure, the patient did not survive despite anti-malarial chemotherapy.
Introduction
Severe multiorgan complications occur in Plasmodium falciparum infection (1) . Multiorgan systems are concurrently affected caused by parasite sequestration in microvasculature and subsequent tissue hypoxia (2) . P. falciparum infection causes renal dysfunction (3) which varies widely from asymptomatic to malarial acute renal failure (4) . Acute renal failure associated with P. falciparum infection is already well recognized (5) , but end-stage chronic renal disease and falciparum malaria comorbidity is a rare condition. In this case report, a teenage male Javanese patient, who underwent regular twice-a-week hemodialysis, had established end-stage chronic renal failure and was infected by P. falciparum. The source of infection was suspected from blood transfusion. This rare comorbidity led to a rapid deterioration of consciousness and metabolic disturbances which had already existed in end-state chronic renal failure.
Case Report
We report a 17-year-old man with end-stage chronic renal failure caused by chronic glomerulonephritis. He had been undergoing twice-a-week hemodialysis for three months before his present admission. From five days before admission, he had complained of high fever followed by sweating and unusual fatigue and had been given an antipyretic by the attending physician in the hemodialysis room. Two days before admission, he went to appeared in the emergency room and complained of high fever and severe fatigue. The laboratory examination revealed severe anemia (hemoglobin level 5.5 g/dL) and he was urged to become admitted to hospital for blood transfusion. Nevertheless, he refused and planned to come to hospital on the day of his hemodialysis session to get the transfusion. Previously, he had had a regular two to three units of packed red blood cell (PRBC) transfusion concurrently with hemodialysis when his hemoglobin level had been below 8 mg/dL. The last PRBC transfusion had been given 4 weeks earlier. Due to economic reasons, the patient did not receive erithropoetin therapy for On the admission day, the patient was transferred from the hemodialysis room to internal medicine ward. His hemodialysis session was postponed because he had to be transfused with PRBC prior to hemodialysis. He looked pale and weak but he was of sound mind. Vital sign examination showed blood pressure 140/90 mmHg, heart rate 130 beats/ minute, respiratory rate 32 times/minute and body temperature 39.5 . Physical examinations were unremarkable. Laboratory examination revealed severe anemia (hemoglobin 5.2 g/dL), thrombocytopenia (platelet count 81×10 3 /μL) and azotemia (blood urea nitrogen 94.5 mg/dL and creatinine 17.3 mg/dL). Other laboratory examinations were within the normal limit (Table 1) . On the first day of hospitalization, the patient underwent hemodialysis with concurrent PRBC transfusion. The hemodialysis session was completed uneventfully, but the patient was hospitalized in the internal medicine ward due to complaints of high fever and chills.
On the second day of hospitalization, patient mental status rapidly deteriorated into somnolent and progressed into coma. Vital sign revealed blood pressure 180/90 mmHg, heart rate 130 beats/minute and body temperature 38.7 . Laboratory examination showed hemoglobin 9.7 g/dL, blood urea nitrogen 86 mg/dL and creatinine 12.9 mg/dL. Blood electrolyte showed hyperkalemia, gas analysis showed mild acidosis and hypoxemia and very low blood glucose level, 34 mg/dL, was observed. Hypoglycemia was recognized and intravenous dextrose was administered. Nevertheless, patient mental status did not recover as expected. No focal lesion was seen in head CT-scan. We planned to perform hemodialysis because we suspected the patient suffered from uremic encephalopathy.
Subsequently, the result of peripheral blood smear was reported. It showed macrogametocytes and late ring phase tro-phozoites of P. falciparum ( Fig. 1 and Fig. 2 ). Parasite density was 3.7%. This result prompted us to reassess the patient with severe falciparum malaria and start giving antimalarial. Anti-malarial medication in full doses must be given as soon as possible after diagnosis (6) . Two classes of drugs are available for the parenteral treatment of severe malaria, the cinchona alkaloids (i.e quinine and quinidine) and the artemisinin derivatives (i.e artesunate, artemether and artemotil). Among artemisinin derivatives, the pharmacokinetic properties of artesunate are superior to the others (6) . Randomized trials comparing parenteral artesunate and quinine from South-East Asia showed the benefit of artesunate (7) . Furthermore, no dosing adjustment is needed during renal failure and there is less of a side effect of hypoglycemia in artesunate (8) . Thus, we administered intravenous artesunate, starting with a loading dose of 2.4 mg/kg bodyweight at hour 0 followed by 1.2 mg/kg bodyweight at hour 12 and hour 24, then 1.2 mg/kg bodyweight every day until day 6. A 15 mg primaquine was administered via nasogastric tube from the first day. Primaquine has gametocytocidal activity against P. falciparum and accelerates mature gametocyte clearance from blood (9) whereas artemisinin derivatives only eradicate young gametocytes (10) . The observation of macrogametocytes in the peripheral blood smear led us to start giving primaquine. Supportive therapy was given according to standard therapy in our hospital.
At 24 hours after the anti-malarial treatment the patient did not arouse from his coma. Indeed, the coma was deepened and accompanied by deteriorating clinical and metabolic parameters. Stress ulcer, metabolic acidosis, acute respiratory distress syndrome and respiratory failure ensued. Prior to being transferred to mechanical ventilation, the patient experienced a general seizure and respiratory arrest. Despite cardiopulmonary resuscitation, the patient eventually
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died.
Discussion
Severe malaria is defined as the clinical organ failures and the presence of the asexual form of P. falciparum in the peripheral blood smear (11) . The types of organ failure found in the present case were coma of cerebral malaria, severe anemia, hypoglycemia, renal failure and respiratory distress. Unfortunately, in the beginning of the disease course, awareness of malarial infection was lacking. Five-day fever, an unusual complaint of a chronic renal disease patient, might have a wide ranging differential diagnosis, especially in a tropical country. Our awareness of malarial infection emerged after ensuing mental status deterioration and metabolic disturbances, despite adequate treatment for renal disease.
In end-stage renal failure, uremic encephalopathy leads to degradation of consciousness and adequate hemodialysis will bring improvement. Hypoglycemia might also account for this condition, but unaltered consciousness after dextrose treatment made the possibility less likely. Hypoglycemia is a common complication of P. falciparum infection (11) . The present patient was likely to develop cerebral malaria. It is sometimes clinically difficult to differentiate between hypoglycemic coma and cerebral malaria (12) . Acidosis, already exists in renal disease, and is worsened in falciparum malaria comorbidity. Falciparum malaria causes lactic acidosis due to anaerobic glycolysis of hypoxic tissue (13) . Coma and acidosis are significant prognostic factors of mortality from severe malaria (14) . Furthermore, end-stage chronic renal failure is an immunocompromised condition. Those with immunocompromised state tend to have a worse clinical course and higher parasitemia once they become infected with malarial parasites, especially P. falciparum (15) . Impaired cell-mediated and humoral immune systems and reduced activities of the immune cells make patients with endstate chronic renal failure susceptible to fatal outcomes from infectious diseases which are the second most common cause of death in these populations (16) .
Curiosity developed pertaining to the source of P. falciparum in the present case. The patient neither had complained of periodic fever nor had malarial infection beforehand. He resided in northern village of Yogyakarta city, which is not a malaria endemic area, and had not travelled to an endemic area recently. Family or community history of malaria was denied by his family members. The history of regular PRBC transfusion was the most suspicious source, despite the screening for malaria in transfused blood product. In malarial endemic countries, there may be more than 50 cases of transfusion-transmitted malaria per million donor units (17) . This occurs mainly from single donor products, such as red cells, platelets, white cell concentrates, cryoprecipitate and frozen red cells after thawing and washing (18) . Malarial screening systems have been performed to all blood products in our transfusion unit, nevertheless the use of Giemsastained films or rapid diagnostic tests for malarial antigen only identify blood donors with parasitemia above the detection limit of these techniques (19) . Subjective screening with questionnaire may not be sufficient to exclude malarialborne blood, since our city, Yogyakarta, was populated by inhabitants coming from all around Indonesia, which has several malarial endemic regions. Furthermore, semiimmune individuals from these regions may not report any symptoms of malaria and become a potential source of transfusion-transmitted malaria.
Based on the present case, first we conclude that underlying chronic organ failure may obscure the metabolic disturbance caused by infectious agents, in our case P. falciparum. This comorbidity led to a fatal outcome due of underlying organ failure, immunosuppressive state and delay of infection diagnosis and treatment. Secondly, the transfusiontransmitted malaria infection occurs despite screening systems for blood donation. Although we could not trace back to the blood donor origin, it was likely that the transfused malarial-borne red blood cells passed through the screening process. A better screening test is necessary to avoid unwanted transfusion-transmitted malaria.
